New techniques for drug delivery to the posterior eye segment

Area of Science:

• Ophthalmology
• Pharmacology
• Biomedical Engineering

Background:

• Posterior segment eye diseases, including age-related macular degeneration and diabetic retinopathy, are leading causes of vision loss.
• Current treatments often involve repeated intravitreal injections, which can lead to ocular complications.
• There is a critical need for improved drug delivery methods for sustained and effective ocular medication.

Purpose of the Study:

• To review recent advancements in ocular drug delivery systems for posterior eye segment diseases.
• To highlight the potential of novel delivery strategies to overcome limitations of current treatments.
• To emphasize transscleral iontophoresis as a promising alternative delivery method.

Main Methods:

• Comprehensive literature review of recent research in ocular drug delivery.
• Analysis of emerging technologies and their application to posterior eye segment diseases.
• Focus on transscleral iontophoresis mechanisms and efficacy.

Main Results:

• New ocular drug delivery systems aim for enhanced drug penetration and prolonged action.
• Improved safety profiles and less invasive administration methods are being developed.
• Transscleral iontophoresis demonstrates potential for effective drug delivery across the sclera.

Conclusions:

• Advances in ocular drug delivery systems are crucial for managing posterior eye diseases.
• Novel approaches promise improved efficacy, safety, and patient compliance.
• Transscleral iontophoresis represents a significant development in non-invasive ocular drug delivery.